id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-4184	Baracca, Maria Francesca; Viviani, Filippo; Pileri, Alessandro; Clarizio, Giacomo; Bardazzi, Federico 	New-Onset Blepharitis in a Patient Treated With Secukinumab for Severe Psoriasis 	2024	2	.pdf	application/pdf	625	53	54	Regarding blepharitis, other cases reported argue that it could be a class AE of IL17A inhibitors: these cytokines are essential for antimicrobial peptide production on the skin surface and their targeting can result in an overgrowth of microorganisms such as Malassezia, which might contribute to the development of eyelid dermatitis [1]. This is a valuable option for eyelid dermatitis that does not clear with topical therapy or often recurs after treatment is stopped.	cache/dpc-4184.pdf	txt/dpc-4184.txt